Initial plasma HIV-1 RNA levels and progression to AIDS in women and men

New England Journal of Medicine

Volumn 344, Issue 10, 2001, Pages 720-725

  Sterling, Timothy R ^a,b,f   Vlahov, David ^a,b,c   Astemborski, Jacquie ^a,b   Hoover, Donald R ^d   Margolick, Joseph B ^a   Quinn, Thomas C ^b,e  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK ACADEMY OF MEDICINE   (United States)

^d RUTGERS UNIVERSITY   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^f Division of Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEX DIFFERENCE; TREATMENT INDICATION; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; ELIGIBILITY DETERMINATION; FEMALE; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; LONGITUDINAL STUDIES; MALE; PRACTICE GUIDELINES; REGRESSION ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK; RNA, VIRAL; SEX FACTORS; VIRAL LOAD;

EID: 0035826051     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200103083441003     Document Type: Article

References (32)

1. The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter
2. Sex differences in HIV-1 viral load and progression to AIDS
3. Serum levels of virus burden in early-stage human immunodeficiency virus type 1 disease in women
4. Sex differences in longitudinal human immunodeficiency virus type 1 RNA levels among seroconverters
5. Longitudinal human immunodeficiency virus type 1 load in the italian Seroconversion Study: Correlates and temporal trends of virus load
6. Gender is not a factor in serum human immunodeficiency virus type 1 RNA levels in patients with viremia
7. Lack of sex difference in CD4 to HIV-1 RNA viral load ratio
8. Sex differences in HIV-1 viral load and progression to AIDS: Swiss HIV Cohort Study
9. Association of race and gender with HIV-1 RNA levels and immunologic progression
10. The natural history of HIV-1 infection: Virus load and virus phenotype independent determinants of clinical course?
11. Quantitation of HIV-1 Riga in plasma predicts outcome after seroconversion
12. Virologic and serologic markers of rapid progression to AIDS after HIV-1 seroconversion
13. Natural history of HIV-1 cell-free viremia
14. Serum levels of human immunodeficiency virus type 1 (HIV-1) RNA after seroconversion: A predictor of long-term mortality in HIV infection
15. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection
16. Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men: Multicenter AIDS Cohort Study
17. Antiretroviral therapy in adults: Updated recommendations of the International AIDS Society-USA Panel
18. Report of NIH Panel to define principles of therapy of HIV infection and guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents
19. The ALIVE study: A longitudinal study of HIV infection in intravenous drug users: Description of methods
20. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
21. Simple and rapid measurement of human T-lymphocytes and their subclasses in peripheral blood
22. Quality control in the flow cytometric measurement of T-lymphocyte subsets: The Multicenter AIDS Cohort Study experience
23. Rapid and simple method for purification of nucleic acids
24. Survival and disease progression according to gender of patients with HIV infection: The Terry Beirn Community Programs for Clinical Research on AIDS
25. Race, sex, drug use, and progression of human immunodeficiency virus disease
26. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: A collaborative re-analysis
27. The case for more cautious, patient-focused antiretroviral therapy
28. The relative value of CD4 cell count and quantitative HIV-1 RNA in predicting survival in HIV-1 infected women: Results of the Women's Interagency HIV Study
29. To start or not to start? Diminished effectiveness of anti-retroviral therapy among patients initiating therapy with CD4+ cell counts below 200/mm3
30. Risk of progression to AIDS and death in HIV infected women initiating HAART at different stages of disease
31. Human immunodeficiency virus RNA levels in US adults: A comparison based on race and ethnicity
32. Direct comparison of time to AIDS and infectious disease death between HIV seroconverter injection drug users in Italy and the United States: Results from the ALIVE and ISS studies: AIDS Link to Intravenous Experiences: Italian Seroconversion Study